James Topper - Director, 10%+ Owner at Phathom Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Topper since 9/18/2023

Holdings reported by James Topper for Phathom Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5.83M $53.1M $9.11 May 23, 2024 By Frazier Life Sciences IX, L.P.
Common Stock 32.1K $292K $9.11 May 23, 2024 Direct
Common Stock 3.91K $35.6K $9.11 May 23, 2024 Indirect
Stock Option (Right to Buy) 17.5K May 23, 2024 Direct Common Stock

Transactions reported by James Topper for Phathom Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.